Abstract
In Mexico, Seguro Popular (SP) was created to reach universal health coverage, including cancer care, through the Fund for Protection Against Catastrophic Expenditure (FPGC). This chapter describes how SP addressed the components of the WHO Access to Medicines Framework on access to cancer medicines.
SP’s reimburserment guidelines cover medicines for basic cancer care and define reference prices, which are similar to international reference prices. Eight percent of SP’s resources are allocated to FPGC, of which 28% finance cancer care. Only accredited health facilities are reimbursed by SP, but their number is insufficient to satisfy demand. Different procurement mechanisms affect the availability of cancer medicines.
Original language | English |
---|---|
Title of host publication | Global Pharmaceutical Policy |
Publisher | Palgrave MacMillan |
Chapter | 7 |
Pages | 177-222 |
Number of pages | 46 |
Edition | 1 |
ISBN (Electronic) | 9789811527241 |
ISBN (Print) | 9789811527234 |
DOIs | |
Publication status | Published - 15-Jun-2020 |
Keywords
- Access
- Cancer medicines
- Financing
- Mexico
- Pricing
- Procurement and supply
- Selection
- WHO access to medicines framework